1-butanol has been researched along with Parkinson Disease in 1 studies
1-Butanol: A four carbon linear hydrocarbon that has a hydroxy group at position 1.
butan-1-ol : A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valálik, I | 1 |
| Emri, M | 1 |
| Lengyel, Z | 1 |
| Mikecz, P | 1 |
| Trón, L | 1 |
| Csókay, A | 1 |
| Márián, T | 1 |
1 other study available for 1-butanol and Parkinson Disease
| Article | Year |
|---|---|
Pallidal deep brain stimulation and L-dopa effect on PET motor activation in advanced Parkinson's disease.
Topics: Analysis of Variance; Antiparkinson Agents; Brain; Brain Mapping; Butanols; Deep Brain Stimulation; | 2009 |